Prognosis
Pre-Election Vaccine Hopes Dim as Regulators Assert Power
- FDA unfurls long-expected guidance for emergency vaccine
- U.S. asks drugmakers to delay filing until they can produce
This article is for subscribers only.
Top officials in charge of making sure that a safe and effective Covid-19 vaccine is swiftly delivered to the American people waved caution flags on Tuesday, all but assuring that a shot won’t be widely available by Election Day.
The Food and Drug Administration has been working for months to hammer out clear standards for vaccines seeking to be fast-tracked to market. The process has placed the agency at odds with the White House, which has wanted to get a shot approved by the time Americans head to the polls on Nov. 3.